To assess the difference in survival of patients treated with interferon (IFN)-alpha or standard chemotherapy, and to establish whether any such difference is greater in a particular patient group.
Assessment of study quality
This review was conducted on individual patient data (IPD). The data were checked for obvious inconsistencies, for balance between treatments within different subgroups and over time, and for apparent discrepancies with any publications. As far as possible, data were to be obtained for all of the patients randomised. Individual trialists were sent tabulations of their own data for checking. The authors do not mention any trials excluded from the review on the grounds of validity.
Data extraction
Once a relevant trial was identified, data on each individual patient were sought. The authors do not state how they obtained the IPD. The IPD included gender, Ph chromosome positivity, platelet and white blood cell counts, Sokal score at diagnosis, dates of birth, diagnosis, and randomisation. The follow-up variables included date last seen alive, date and type of response, date and type of any bone marrow transplant, and date and cause of death.
